Journal article
Exacerbations of severe asthma in patients treated with mepolizumab
- Abstract:
-
Extract: Mepolizumab, a humanised monoclonal antibody that neutralises interleukin-5, reduces exacerbations of severe eosinophilic asthma and chronic obstructive pulmonary disease (COPD) [1, 2]. The beneficial effect of treatment is most obvious in patients with a raised peripheral blood eosinophil count, a group who are at high risk of exacerbation off treatment [2, 3]. Even in this population, exacerbation rates whilst receiving mepolizumab are around one per patient per ye... Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Publisher copy:
- 10.1183/13993003.01127-2018
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Bibliographic Details
- Publisher:
- European Respiratory Society Publisher's website
- Journal:
- European Respiratory Journal Journal website
- Volume:
- 52
- Issue:
- 6
- Pages:
- 1801127
- Publication date:
- 2018-10-13
- Acceptance date:
- 2018-10-04
- DOI:
- EISSN:
-
1399-3003
- ISSN:
-
0903-1936
- Pmid:
-
30464012
- Source identifiers:
-
948858
Item Description
- Language:
- English
- Pubs id:
-
pubs:948858
- UUID:
-
uuid:68bd8800-e88d-4a0c-8b75-2591f05749cb
- Local pid:
- pubs:948858
- Deposit date:
- 2019-02-06
Terms of use
- Copyright holder:
- European Respiratory Society
- Copyright date:
- 2018
- Notes:
- Copyright ©ERS 2018
If you are the owner of this record, you can report an update to it here: Report update to this record